Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 184,135 | 116,222 | 143,663 | 160,471 | 173,943 |
| Receivables | 50,507 | 488 | 488 | 488 | 488 |
| Other current assets | 418 | 283 | 169 | 898 | 5,416 |
| TOTAL | $247,692 | $134,053 | $161,754 | $183,048 | $188,304 |
| Non-Current Assets | |||||
| PPE Net | 23,053 | 23,874 | 25,154 | 31,536 | 32,780 |
| Investments And Advances | 4,442 | 5,890 | 6,842 | 812 | 0 |
| Intangibles | 1,995 | 2,021 | 2,048 | 2,074 | 1,343 |
| Other Non-Current Assets | 19,981 | 15,513 | 15,700 | 9,729 | 7,687 |
| TOTAL | $49,471 | $47,298 | $49,744 | $44,151 | $41,810 |
| Total Assets | $297,163 | $181,351 | $211,498 | $227,199 | $230,114 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 797 | 699 | 1,144 | 486 | 478 |
| Accrued Expenses | 8,236 | 5,227 | 10,793 | 7,556 | 7,452 |
| Other current liabilities | 1,449 | 1,620 | 977 | 1,880 | 1,609 |
| TOTAL | $53,923 | $29,106 | $35,980 | $36,475 | $36,251 |
| Non-Current Liabilities | |||||
| Long Term Debt | 22,119 | 2,482 | 2,478 | N/A | N/A |
| Deferred Revenues | 41,514 | 19,686 | 21,244 | 21,976 | 22,221 |
| Other Non-Current Liabilities | 14,050 | 14,361 | 14,857 | 17,443 | 18,009 |
| TOTAL | $140,217 | $82,586 | $84,350 | $89,281 | $93,310 |
| Total Liabilities | $194,140 | $111,692 | $120,330 | $125,756 | $129,561 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,690 | 2,070 | 2,033 | 2,024 | 1,984 |
| Retained earnings | -375,878 | -344,843 | -316,675 | -294,385 | -283,106 |
| Other shareholders' equity | 48 | 48 | 48 | 48 | 48 |
| TOTAL | $103,023 | $69,659 | $91,168 | $101,443 | $100,553 |
| Total Liabilities And Equity | $297,163 | $181,351 | $211,498 | $227,199 | $230,114 |